Track topics on Twitter Track topics that are important to you
Tricida Inc. (developing non-absorbed oral therapies for kidney disease) raised $57.5mm in its Series D round. New investors ...
Original Article: Tricida completes $57.5mm Series D roundNEXT ARTICLE
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...